Unknown PHASE3 INTERVENTIONAL 2-arm NCT03178747

Tzanck Smear With Methylene Blue Stain for Herpes

A Comparative Study of Tzanck Smear With Methylene Blue Versus Giemsa Stain to Diagnose Herpes Simplex, Herpes Zoster and Varicella Zoster Skin Infections

Sponsor: Chulalongkorn University

Conditions Herpes Simplex Herpes Zoster Varicella Zoster

Interventions Giemsa stain Methylene blue

Updated 6 times since 2017 Last updated: Aug 3, 2017 Started: Mar 7, 2017 Primary completion: Dec 7, 2017 Completion: Mar 6, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Herpes Simplex and Herpes Zoster, this trial is ongoing. The trial is conducted by Chulalongkorn University and has accumulated 6 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Sep 2019 — Jan 2021 [monthly]

Unknown Status PHASE3

Status: Recruiting → Unknown Status
Jun 2018 — Sep 2019 [monthly]

Recruiting PHASE3

▶ Show 1 earlier version

Jun 2017 — Jun 2018 [monthly]

Recruiting PHASE3

First recorded

Mar 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chulalongkorn University
Dermatological Society of Thailand

Data source: Chulalongkorn University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bangkok, Thailand